#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A Comparison of the Reactivating Efficacy of New Asymmetric Bispyridinium Oxime BI-6with Oximes HI-6 and Obidoxime on Soman-Inhibited Acetylcholinesterase in the Diaphragm and Various Parts ofthe Rat Brain


Authors: J. Kassa;  J. Bajgar
Authors‘ workplace: Vojenská lékařská akademie JEP, Hradec Králové
Published in: Čas. Lék. čes. 1999; : 532-535
Category:

Overview

Background.
Acute poisoning with the highly toxic organophosphorus agent, soman, is not treated satisfactorilyeven by the most modern antidotes.Methods and Results. In experiments on rats, the reactivating effect of a new asymmetric bispyridinium oxime BI-6was compared with widely used oximes HI-6 and obidoxime by investigating the changes of soman-inhibited acetylcho-linesterase activity in the diaphragm and various parts of the brain in rats up to three hours following soman challenge.Our findings confirm that the new oxime BI-6 is a more effective reactivator of soman-inhibited acetylcholines-terase than obidoxime but not as effective as the oxime HI-6 expecially in the peripheral compartment.Conclusions. The new oxime BI-6 is not as effective as HI-6 which seems to have definite advantages over otheroximes in the treatment of soman poisoning.

Key words:
soman, BI-6, HI-6, obidoxime, acetylcholinesterase, diaphragm, brain, rat.

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#